Literature DB >> 21396579

The shortest of the short: pericentrin mutations and beyond.

Anita Rauch1.   

Abstract

Microcephalic or Majewski's osteodysplastic primordial dwarfism type II (MOPD II) represents the most common type of primordial dwarfism. Adult height is typically about one meter and short stature is becoming mildly disproportionate over time with mild skeletal anomalies. Mental development is usually borderline or within the low normal range but cerebrovascular events that are common in childhood can result in significant cognitive impairment and cerebral palsy. Despite cerebrovascular insults, cardiomyopathy and early onset type 2 diabetes contribute to early mortality and morbidity. Common minor clinical features are truncal obesity, high pitched voice, microdontia and pigmentary changes. MOPD II is caused by autosomal recessive loss of function mutations in the PCNT gene encoding for a key centrosomal protein. There is clinical overlap with the so called Seckel syndrome, a heterogeneous group of entities with at least four different gene loci known to date.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396579     DOI: 10.1016/j.beem.2010.10.015

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  14 in total

Review 1.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease.

Authors:  Angela L Duker; Dagmar Kinderman; Christy Jordan; Tim Niiler; Carissa M Baker-Smith; Louise Thompson; David A Parry; Ricki S Carroll; Michael B Bober
Journal:  Orphanet J Rare Dis       Date:  2021-05-20       Impact factor: 4.123

3.  Renal Dysplasia and Precocious Diabetes Onset in Microcephalic Osteodysplastic Primordial Dwarfism Type II Syndrome: A Case Report.

Authors:  Raquel Segovia-Ortí; Natalia Espinosa de Los Monteros Aliaga Cano; Javier Lumbreras; Diego de Sotto-Esteban; María Dolores Rodrigo
Journal:  J Pediatr Genet       Date:  2020-09-07

4.  Identification of two novel critical mutations in PCNT gene resulting in microcephalic osteodysplastic primordial dwarfism type II associated with multiple intracranial aneurysms.

Authors:  Fei-Feng Li; Xu-Dong Wang; Min-Wei Zhu; Zhi-Hong Lou; Qiong Zhang; Chun-Yu Zhu; Hong-Lin Feng; Zhi-Guo Lin; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2015-08-01       Impact factor: 3.584

5.  Microcephalic osteodysplastic primordial dwarfism type II (MOPD II) with multiple vascular complications misdiagnosed as Dubowitz syndrome.

Authors:  Jana-Katharina Dieks; Alessandra Baumer; Ekkehard Wilichowski; Anita Rauch; Matthias Sigler
Journal:  Eur J Pediatr       Date:  2014-06-29       Impact factor: 3.183

6.  Pericentrin expression in Down's syndrome.

Authors:  Michele Salemi; Concetta Barone; Carmelo Romano; Roberto Salluzzo; Filippo Caraci; Rita Anna Cantarella; Maria Grazia Salluzzo; Filippo Drago; Corrado Romano; Paolo Bosco
Journal:  Neurol Sci       Date:  2013-08-27       Impact factor: 3.307

Review 7.  Mechanisms and pathways of growth failure in primordial dwarfism.

Authors:  Anna Klingseisen; Andrew P Jackson
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

8.  Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts.

Authors:  Hannah S E Tivey; Michal J Rokicki; James R Barnacle; Matthew J Rogers; Mark C Bagley; David Kipling; Terence Davis
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-02-11       Impact factor: 6.053

9.  Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence.

Authors:  Terence Davis; Hannah S E Tivey; Amy J C Brook; David Kipling
Journal:  Biogerontology       Date:  2014-09-12       Impact factor: 4.277

10.  Truncation of POC1A associated with short stature and extreme insulin resistance.

Authors:  Jian-Hua Chen; Maria Segni; Felicity Payne; Isabel Huang-Doran; Alison Sleigh; Claire Adams; David B Savage; Stephen O'Rahilly; Robert K Semple; Inês Barroso
Journal:  J Mol Endocrinol       Date:  2015-10       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.